Related Experiment Video

Updated: Mar 20, 2026

Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome
07:23

Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome

Published on: June 15, 2016

9.0K

Novel mechanisms of regulation of miRNAs in CLL

Veronica Balatti1, Mario Acunzo1, Yuri Pekarky1

  • 1Department of Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, Wexner Medical Center, The Ohio State University, Columbus, OH, USA.

Trends in Cancer
|May 24, 2016
PubMed

Insights

MicroRNAs play a key role in chronic lymphocytic leukemia (CLL) development and progression. Understanding microRNA deregulation offers new avenues for identifying biomarkers and therapeutic targets for CLL.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • B-cell chronic lymphocytic leukemia (CLL) is the most prevalent adult human leukemia.
  • The precise molecular mechanisms, including oncogene and tumor suppressor roles, driving CLL pathogenesis remain under investigation.
  • MicroRNAs (miRNAs), small non-coding RNAs regulating gene expression, are implicated in various cancers.

Purpose of the Study:

  • To review recent findings on the role of microRNAs in the onset and progression of CLL.
  • To explore the potential of microRNAs as biomarkers for CLL diagnosis and prognosis.
  • To discuss the therapeutic implications of targeting microRNAs in CLL treatment.

Main Methods:

  • Literature review of recent studies on microRNAs in CLL.
  • Analysis of microRNA expression patterns and their correlation with CLL development.
  • Examination of the oncogenic or tumor-suppressive functions of specific microRNAs in CLL.

Main Results:

  • MicroRNAs are frequently deregulated in CLL, influencing genes critical for leukemogenesis.
  • Specific microRNAs can act as oncogenes or tumor suppressors, impacting CLL progression.
  • Altered microRNA profiles are associated with distinct CLL subtypes and clinical outcomes.

Conclusions:

  • MicroRNAs are significant players in CLL pathogenesis, affecting both disease initiation and advancement.
  • MicroRNA deregulation presents promising opportunities for developing novel diagnostic biomarkers and therapeutic strategies for CLL.
  • Further research into microRNA function and regulation is crucial for advancing CLL treatment.
Keywords:
CLLmiR-15/16microRNA

More Related Videos

Comprehensive DNA Methylation Analysis Using a Methyl-CpG-binding Domain Capture-based Method in Chronic Lymphocytic Leukemia Patients13:21

Comprehensive DNA Methylation Analysis Using a Methyl-CpG-binding Domain Capture-based Method in Chronic Lymphocytic Leukemia Patients

Published on: June 16, 2017

10.7K
Genome-wide Analysis of HDAC Inhibitor-mediated Modulation of microRNAs and mRNAs in B Cells Induced to Undergo Class-switch DNA Recombination and Plasma Cell Differentiation11:06

Genome-wide Analysis of HDAC Inhibitor-mediated Modulation of microRNAs and mRNAs in B Cells Induced to Undergo Class-switch DNA Recombination and Plasma Cell Differentiation

Published on: September 20, 2017

6.6K

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.2K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.6K
MicroRNAs01:22

MicroRNAs

12.0K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
10.1K
Regulation of Expression Occurs at Multiple Steps02:24

Regulation of Expression Occurs at Multiple Steps

Gene expression can be regulated at almost every step from gene to protein. Transcription is the step that is most commonly regulated. This involves the binding of proteins to short regulatory sequences on the DNA. This association can either promote or inhibit the transcription of a gene associated with the respective sequence.
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...
26.9K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
3.0K